Clinical trial
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III…
NCT00103116 · Edward Hirschowitz, Other · Completed
Key facts
| NCT number | NCT00103116 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer |
| Official title | Autologous Dendritic Cell Vaccines in Non-small Cell Lung Cancer (NSCLC) |
| Lead sponsor | Edward Hirschowitz, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Biological |
| Interventions | autologous dendritic cell cancer vaccine |
| Enrollment | 32 |
| Start date | Oct 1, 2004 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Feb 8, 2005 |
| Last update posted | Apr 4, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: